- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
BabyFace software puts fetus in 3-D
At the end of last month, Misonix and Sonora Medical Systems received FDA approval for a 3-D surface-rendering tool called BabyFace that, when plugged into a standard ultrasound system, transforms a 2-D image of a fetus into 3-D.The system uses a
At the end of last month, Misonix and Sonora Medical Systems received FDA approval for a 3-D surface-rendering tool called BabyFace that, when plugged into a standard ultrasound system, transforms a 2-D image of a fetus into 3-D.
The system uses a transducer with an integrated motion-tracking sensor and a compact electronic box with a miniature computer. Product developers of BabyFace say the software can connect easily to conventional ultrasound systems.
Sonora, a distributor of previously owned and refurbished medical imaging systems, developed BabyFace with Biomedicom of Israel. Biomedicom is a spin-off of Mountain View, CA-based Silicon Graphics. Misonix President Michael A. McManus said his company will market the rendering tool aggressively. Misonix has a larger than 50% interest in Sonora.
Integrated Equipment Solutions, distributor of BabyFace, showed off the software at the American Institute of Ultrasound Medicines convention in San Francisco this month. BabyFace will also be shown at the May 2224 American College of Obstetricians and Gynecologists meeting in San Francisco.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,00 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
